Skip to Main Content
Back to News

ORTHOFIX MEDICAL Earnings Results: $OFIX Reports Quarterly Earnings

None

ORTHOFIX MEDICAL ($OFIX) posted quarterly earnings results on Tuesday, August 5th. The company reported earnings of $0.13 per share, beating estimates of -$0.50 by $0.63. The company also reported revenue of $203,120,000, beating estimates of $200,828,208 by $2,291,792.

You can see Quiver Quantitative's $OFIX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ORTHOFIX MEDICAL Insider Trading Activity

ORTHOFIX MEDICAL insiders have traded $OFIX stock on the open market 15 times in the past 6 months. Of those trades, 8 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $OFIX stock by insiders over the last 6 months:

  • CAPITAL MANAGEMENT, LP ENGINE has made 4 purchases buying 101,250 shares for an estimated $1,244,881 and 0 sales.
  • MASSIMO CALAFIORE (President & CEO) purchased 10,000 shares for an estimated $125,399
  • ALAN LEE BAZAAR has made 3 purchases buying 6,240 shares for an estimated $74,861 and 0 sales.
  • LUCAS VITALE (CP&BOO) sold 4,287 shares for an estimated $71,164
  • JORGE ANDRES CEDRON (CLO) sold 3,816 shares for an estimated $50,790
  • AVIVA MCPHERRON (Pres, Global Ops & Qual) sold 3,728 shares for an estimated $39,181
  • MAX REINHARDT (President, Global Spine) sold 1,643 shares for an estimated $19,124
  • GEOFFREY C GILLESPIE (CAO) has made 0 purchases and 3 sales selling 559 shares for an estimated $9,490.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ORTHOFIX MEDICAL Hedge Fund Activity

We have seen 77 institutional investors add shares of ORTHOFIX MEDICAL stock to their portfolio, and 68 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ORTHOFIX MEDICAL Analyst Ratings

Wall Street analysts have issued reports on $OFIX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barrington Research issued a "Outperform" rating on 06/23/2025
  • Canaccord Genuity issued a "Buy" rating on 02/26/2025
  • Roth MKM issued a "Buy" rating on 02/26/2025

To track analyst ratings and price targets for ORTHOFIX MEDICAL, check out Quiver Quantitative's $OFIX forecast page.

ORTHOFIX MEDICAL Price Targets

Multiple analysts have issued price targets for $OFIX recently. We have seen 3 analysts offer price targets for $OFIX in the last 6 months, with a median target of $22.0.

Here are some recent targets:

  • Michael Petusky from Barrington Research set a target price of $16.0 on 06/23/2025
  • Caitlin Burrows from Canaccord Genuity set a target price of $24.0 on 02/26/2025
  • Jason Wittes from Roth MKM set a target price of $22.0 on 02/26/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles